REPL Replimune Group, Inc.
Healthcare$4.60+0.00%OpenMarket Cap: $379.7M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$14.00
Target (Median)
$14.00
Target Range
$14.00 - $14.00
Upside from current price: 204.5%
Rating Distribution
0 Strong Buy0 Buy5 Hold2 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-13 | HC Wainwright & Co. | downgrade | Sell | Buy |
| 2026-04-13 | Cantor Fitzgerald | downgrade | Neutral | Overweight |
| 2026-04-13 | Leerink Partners | downgrade | Market Perform | Outperform |
| 2026-04-13 | JP Morgan | downgrade | Underweight | Neutral |
| 2026-04-13 | Jefferies | downgrade | Hold | Buy |
| 2026-04-13 | Wedbush | downgrade | Neutral | Outperform |
| 2026-02-05 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-04 | Wedbush | maintain | Outperform | Outperform |
| 2025-11-03 | BMO Capital | upgrade | Market Perform | Underperform |
| 2025-10-27 | HC Wainwright & Co. | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Wed Mar 31 | $-1.63 | $10.7M | 5 |
| Fri Mar 31 | $-0.91 | $9.9M | 5 |
| Sat Mar 31 | $0.00 | $120.3M | 3 |
| Sun Mar 31 | $0.41 | $149.2M | 1 |